Clinical trial registry changes: August 2026

Among the trials TrialRedline tracks, 71 changed their ClinicalTrials.gov record in August 2026: 5 status changes to terminated, withdrawn or suspended, 10 primary outcome text edits, 16 completion dates moved later, 3 completion dates moved earlier, 20 enrollment changes, 35 other status changes. Each entry shows the previous and updated value and links to the registry's own version comparison.

71Trials with a recorded change
72Registry updates
55Sponsors

Trials terminated, withdrawn or suspended

5 in August 2026. Recruitment status changed to Terminated, Withdrawn or Suspended. Terminated first, then newest.

Primary outcome text edits

10 in August 2026. The text of the main study measures changed. Edits to capitalization, punctuation or spacing alone are left out. Newest first.

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Progression-free survival (PFS) as assessed by Independent Review Committee (IRC). After: Measure: Progression-free survival (PFS) as assessed by Independent Review Committee (IRC) Measure: Objective response rate (ORR) without partial response with lymphocytosis (PR-L) as assessed by IRC.

Check registry source

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from Baseline in performance on the Cogstate Cognition battery*. After: Measure: Change from Baseline in performance on the Cogstate Cognition battery* Measure: Change from Baseline in PROMIS Cognitive Function Short Form 8a (SF-8a) Measure: Change from Baseline in PROMIS Fatigue Short Form 13a (SF-13a) Measure: Change from Baseline in PROMIS Sleep Disturbance Short Form 8a (SF-8a) Measure: Change from Baseline in SF-12 Health Survey (Physical Component Scores) Measure: Change from Baseline in SF-12 Health Survey (Mental Component Scores) Measure: Change from Baseline in DePaul Symptom Questionnaire (DSQ) Post-Exertional Malaise Measure: Composite Benefit Score.

Check registry source

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change in Montgomery-Åsberg Depression Rating Scale (MADRS) score. Measure: Frequency and severity of treatment-emergent adverse events (TEAEs), treatment-emergent serious adverse events (SAEs), and TEAEs leading to treatment discontinuations.. After: Measure: Change in Montgomery-Åsberg Depression Rating Scale (MADRS) Score..

Check registry source

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Part A: Incidence of treatment-emergent adverse events (TEAEs), adverse events of special interest (AESIs), and serious adverse events (SAEs) Measure: Part B: Area under the concentration-time curve (AUC) of C-peptide after a 2 hour mixed meal tolerance test (MMTT). After: Measure: Part A: Incidence of treatment-emergent adverse events (TEAEs), adverse events of special interest (AESIs), and serious adverse events (SAEs) Measure: Part B: Area under the concentration-time curve (AUC) of C-peptide after a 2 hour mixed meal tolerance test (MMTT) Measure: Part C: Area under the concentration-time curve (AUC) of C-peptide after a 2-hour mixed meal tolerance test (MMTT)..

Check registry source

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: To evaluate incidence of adverse events. After: Measure: Phase 1/2: To evaluate incidence of adverse events Measure: Phase 2b Sub-study: To evaluate the efficacy of CABA-201 on % predicted forced vital capacity (FVC) in SSc-ILD subjects.

Check registry source

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Relative (%) change in liver stiffness by VCTE compared to baseline at Week 24. After: Measure: Relative (%) reduction in liver stiffness by VCTE compared to baseline.

Check registry source

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from baseline in the MDS-UPDRS Part III. After: Measure: Monocyte Lymphocyte Ratio (MLR).

Check registry source

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Occurrence of treatment emergent AEs (TEAEs). After: Measure: Percentage of Participants With ≥1 Treatment-Emergent Adverse Events (TEAEs) Measure: Percentage of Participants With ≥1 Serious Adverse Events (SAEs).

Check registry source

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Long-term Safety. After: Measure: Time from randomization to relapse of binge eating in the RW segment.

Check registry source

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change in AHI, Combined AD109 Dose Arms vs. Combined Placebo Arms. After: Measure: Change in Apnea-Hypopnea Index (AHI4) From Baseline: Combined AD109 Arms vs. Placebo.

Check registry source

Completion dates moved later

16 in August 2026. Primary completion date moved later while its type (estimated or actual) stayed the same. Largest move first.

Completion dates moved earlier

3 in August 2026. Primary completion date moved earlier while its type stayed the same. Largest move first.

Enrollment changes

20 in August 2026. The participant count changed. Planned and actual counts are shown as recorded. Newest first.

Other recruitment status changes

35 in August 2026. Any other change of recruitment status, such as recruiting to completed. Newest first.

Showing 25 of 35. Browse all tracked trials to open the rest.

Cite this report

TrialRedline, “Clinical trial registry changes: August 2026”. https://trialredline.com/reports/2026-08

Based on public ClinicalTrials.gov record history. How we collect and check the data